ClinImmune Cell & Gene Therapy
ClinImmune Cell & Gene Therapy is a private Aurora, Colorado-based clinical lab services firm offering HLA typing, cord blood banking, clinical trial support, and regulatory medicine across the cell and gene therapy stack for biopharma and transplant-program clients.
- Company typePrivate
- Founded-
- HeadquartersAurora, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ClinImmune Cell & Gene Therapy does
ClinImmune Cell & Gene Therapy is a private, for-profit clinical laboratory services company headquartered in Aurora, Colorado, employing 51-100 people. The firm operates across the cell and gene therapy stack, offering four interlocking service lines: clinical trial support, HLA lab services, cord blood banking, and regulatory medicine, with gene therapy positioned as a core area of activity. Functionally, it functions as a specialty lab and clinical services partner rather than a therapeutic product developer, supporting transplant immunology (via HLA typing), hematopoietic stem cell / cord blood storage, and biotech sponsors requiring clinical trial infrastructure and regulatory expertise in advanced therapies. The Aurora location places it in close proximity to the University of Colorado Anschutz Medical Campus, a major academic and clinical research hub, which is consistent with its clinical-trial and HLA-typing orientation.
Its service portfolio indicates a B2B / institutional revenue model: clinical trial support and HLA typing are typically sold to biopharma sponsors, academic medical centers, and transplant programs, while cord blood banking combines public-bank contract revenue with potential family-directed storage fees, and regulatory medicine is typically delivered as consulting or protocol services to gene therapy developers. The company is privately held with no disclosed funding rounds, parent company, or M&A history in the source material, and its public-facing website content was inaccessible at the time of data collection. Detailed pricing, customer mix, geographic footprint, and segment economics are not available in the input, which limits a more granular read on revenue mechanics and customer concentration.
ClinImmune Cell & Gene Therapy firmographics
Firmographics- Name
- ClinImmune Cell & Gene Therapy
- Website
- https://clinimmune.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ClinImmune Cell & Gene Therapy is a private Aurora, Colorado-based clinical lab services firm offering HLA typing, cord blood banking, clinical trial support, and regulatory medicine across the cell and gene therapy stack for biopharma and transplant-program clients.
- Ownership category
- akta.pro rank
ClinImmune Cell & Gene Therapy industry classification
Industry- Product category
- Cell and Gene Therapy Laboratory Services
- NAICS
- Medical Laboratories (621511), Blood and Organ Banks (621991)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
- akta.pro secondary industries
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)
Keywords
Where ClinImmune Cell & Gene Therapy is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- United States
- HQ region
- North America
Markets served
ClinImmune Cell & Gene Therapy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
ClinImmune Cell & Gene Therapy product offering
Product offeringCore offering
ClinImmune Labs provides a suite of cell and gene therapy-related services, including clinical trial support, HLA laboratory testing, cord blood banking, gene therapies, and regulatory medicine. The company operates from Aurora, United States, as a for-profit private organization with 51–100 employees.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Support
Companies that use ClinImmune Cell & Gene Therapy
Customer profileIdeal customer profiles2 records
ClinImmune Cell & Gene Therapy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ClinImmune Cell & Gene Therapy partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
ClinImmune Cell & Gene Therapy competitors and assessment
Company assessmentDirect peers
- Thermo Fisher Scientific (One Lambda): Through its One Lambda business, Thermo Fisher is the leading provider of HLA typing reagents and transplant diagnostics services. It competes directly with ClinImmune's HLA lab services and is the most established specialist in the same niche.
- CareDx: CareDx focuses on transplant surveillance and HLA-related diagnostics for solid-organ and stem cell transplant patients. It is a leading specialty transplant diagnostics competitor with overlapping HLA testing services.
- Immucor: Immucor provides transfusion and transplantation diagnostics, including HLA reagents and instruments used in HLA typing workflows. Its product and lab-service mix closely overlaps with ClinImmune's HLA lab and transplant support services.
- StemCyte: StemCyte operates one of the largest private cord blood banks globally and supplies cord blood units for transplantation. It directly mirrors ClinImmune's cord blood banking line and overlaps on hematopoietic cell therapy supply.
- ViaCord (Cord Blood Registry): ViaCord and CBR are direct-to-consumer cord blood banking businesses, competing with ClinImmune's cord blood banking service for the same new-parent customer segment.
- Cryo-Cell International: Cryo-Cell operates private cord blood and tissue banking services for families. It competes with ClinImmune for the consumer cord-blood-banking market with the same long-duration storage contract model.
- ACM Global Laboratories: ACM Global provides central laboratory services for clinical trials across multiple therapeutic areas. It is directly comparable to ClinImmune's clinical trial support / central lab service line.
- Cenetron Diagnostics (previously Eurofins Viracor): Cenetron / Eurofins Viracor offers specialty immunology, infectious disease, and transplant-related laboratory testing. It overlaps with ClinImmune's HLA and transplant-support lab services and competes in biomarker/immunology testing.
Broad incumbents
- LabCorp: LabCorp is one of the two largest clinical laboratory companies in the US, offering a broad menu of diagnostic tests including transplant and HLA services through specialty units. It is a broad incumbent that competes with ClinImmune primarily on routine and reference testing.
- Quest Diagnostics: Quest Diagnostics is a national clinical laboratory chain with extensive HLA and transplant testing capabilities. As a broad incumbent, it is a comparable reference and specialty testing player but does not specialize solely in the transplant/CGT niche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
ClinImmune Cell & Gene Therapy social profiles
Digital presenceClinImmune Cell & Gene Therapy financial estimates
Financial estimateRevenue estimate
Valuation estimate
ClinImmune Cell & Gene Therapy leadership team
Management profileNumber of profiles
ClinImmune Cell & Gene Therapy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ClinImmune Cell & Gene Therapy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ClinImmune Cell & Gene Therapy
What does ClinImmune Cell & Gene Therapy do?
ClinImmune Labs provides a suite of cell and gene therapy-related services, including clinical trial support, HLA laboratory testing, cord blood banking, gene therapies, and regulatory medicine. The company operates from Aurora, United States, as a for-profit private organization with 51–100 employees.
When was ClinImmune Cell & Gene Therapy founded?
ClinImmune Cell & Gene Therapy was founded in -1. It employs 11 to 50 people.
Where is ClinImmune Cell & Gene Therapy based?
ClinImmune Cell & Gene Therapy is headquartered in Aurora, United States, in the North America region.
Who are ClinImmune Cell & Gene Therapy's main competitors?
Direct peers on record are Thermo Fisher Scientific (One Lambda), CareDx, Immucor, StemCyte, ViaCord (Cord Blood Registry), Cryo-Cell International, ACM Global Laboratories and Cenetron Diagnostics (previously Eurofins Viracor). Broad incumbents are LabCorp and Quest Diagnostics.
Does ClinImmune Cell & Gene Therapy have an API?
No public API is recorded for ClinImmune Cell & Gene Therapy.
What industry is ClinImmune Cell & Gene Therapy in?
ClinImmune Cell & Gene Therapy's product category is Cell and Gene Therapy Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.